CANDACE LAPLANT: Open Payments
NPI 1073219739 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 75 payments from 18 companies in 2025. Trend: 2023 $276 · 2024 $810 · 2025 $1,361
Food & beverage: $1,361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $308 |
| Lilly USA, LLC | 15 | $215 |
| AstraZeneca Pharmaceuticals LP | 10 | $186 |
| Axsome Therapeutics, Inc. | 6 | $114 |
| Novo Nordisk Inc | 5 | $80 |
| Phathom Pharmaceuticals, Inc. | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Viatris Specialty LLC | 2 | $43 |
| PFIZER INC. | 2 | $41 |
Products named: MOUNJARO, UBRELVY, Auvelity, AIRSUPRA, QULIPTA, VOQUEZNA, KISUNLA, VRAYLAR.
Industry payments across MO — which companies pay providers there.
